CL
Celldex Therapeutics, Inc.
CLDX · NASDAQ
$33.51 -8.44% (-$3.09)
1M -17.40%
Market Cap $2.52B
P/E Ratio -
Div. Yield -
ROE 52.36%
Bulios Fair Price
$16.93
49.5% downside
Trenutna cena
$33.51
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica CLDX trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
29 /100
Expensive P/B 3.53x
P/S 22,510.20x
PEG N/A
Growth
22 /100
Declining Book val. growth 17.35%
Rev. growth 13.98%
FCF growth N/A
Profitability
0 /100
Weak FCF margin 215,908.00%
Op. margin 290,948.00%
Gross margin 56,850.90%
Quality
0 /100
Poor Asset turnover 0.00x
ROA 38.42%
ROIC 45.10%
Debt
100 /100
Low Current ratio 11.82x
Debt/Equity 0.01x
Net debt/EBITDA N/A
Stability
42 /100
Moderate Profitable years 0
EPS volatility 37.64%
Beta 0.84x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CLDX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Anthony S. Marucci
Employees
198
Headquarters
Hampton
Prihajajoči dogodki
09 NOV.
Earnings
Upcoming earnings report